BioSpace News Archive

If confirmed, Susan Monarez will have her work cut out for her, facing a measles outbreak that has already killed two people—the first measles-related deaths in the U.S. since 2015.

March 25, 2025

·

2 min read

·

Tristan Manalac

Press Releases

FDA Grants Priority Review for Biologics License Application (BLA) and EMA Accepts Marketing Authorisation Application (MAA) for Apitegromab as a Treatment for Spinal Muscular Atrophy

March 25, 2025

·

9 min read

Glasses and lenses for correcting vision on a colored background. High quality photo

Drug development

Opthea, UNITY Fail to Unseat Regeneron’s Eylea in Vision Disorders

The Eylea franchise was in need of a win after an appellate court last week denied the pharma’s bid to block Amgen’s biosimilar from the U.S.

March 25, 2025

·

2 min read

·

Tristan Manalac

Sale discounts and promotions. Loans and mortgages. Cashback shopping bonus. Rising borrowing payments

Policy

Trump Doubles Down on Pharma Tariff Threats

President Donald Trump’s tariffs on pharmaceuticals “to come at some point,” per CNBC, as companies promise to build infrastructure in the U.S.

March 25, 2025

·

2 min read

·

Tristan Manalac

South San Francisco, CA, USA - May 1, 2022: Exterior view of the Merck Researches Laboratories in South San Francisco, California. Merck & Co., Inc. is a global pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme (MSD) outside the United States and Canada.

Collaboration

Merck Commits Nearly $2B for Oral Lipid-Lowering Drug from Chinese Biotech

Merck joins a growing list of companies targeting lipoprotein(a), high levels of which are associated with an elevated risk of adverse cardiovascular outcomes.

March 25, 2025

·

2 min read

·

Tristan Manalac